Conmed Corp. (NASDAQ:CNMD) EVP Daniel Jonas sold 1,500 shares of Conmed Corp. stock in a transaction that occurred on Tuesday, November 8th. The shares were sold at an average price of $41.78, for a total transaction of $62,670.00. Following the sale, the executive vice president now owns 16,590 shares in the company, valued at approximately $693,130.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Daniel Jonas also recently made the following trade(s):

  • On Monday, November 7th, Daniel Jonas sold 2,555 shares of Conmed Corp. stock. The stock was sold at an average price of $40.40, for a total transaction of $103,222.00.

Conmed Corp. (NASDAQ:CNMD) opened at 43.90 on Friday. The firm has a market cap of $1.22 billion, a P/E ratio of 78.39 and a beta of 0.81. Conmed Corp. has a 12-month low of $35.51 and a 12-month high of $50.16. The firm has a 50-day moving average of $39.99 and a 200-day moving average of $41.91.

Conmed Corp. (NASDAQ:CNMD) last announced its earnings results on Thursday, October 27th. The medical technology company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01. The firm earned $184.79 million during the quarter, compared to analysts’ expectations of $180.13 million. Conmed Corp. had a return on equity of 8.26% and a net margin of 2.11%. The company’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.45 earnings per share. On average, analysts expect that Conmed Corp. will post $1.87 EPS for the current year.

Insider Buying and Selling by Quarter for Conmed Corp. (NASDAQ:CNMD)

A number of large investors have recently made changes to their positions in CNMD. PineBridge Investments L.P. boosted its stake in shares of Conmed Corp. by 3.9% in the second quarter. PineBridge Investments L.P. now owns 3,273 shares of the medical technology company’s stock worth $157,000 after buying an additional 124 shares during the last quarter. Teacher Retirement System of Texas raised its position in shares of Conmed Corp. by 14.0% in the second quarter. Teacher Retirement System of Texas now owns 3,490 shares of the medical technology company’s stock worth $167,000 after buying an additional 429 shares during the period. SG Americas Securities LLC acquired a new position in shares of Conmed Corp. during the third quarter worth approximately $173,000. Suntrust Banks Inc. acquired a new position in shares of Conmed Corp. during the second quarter worth approximately $205,000. Finally, CNA Financial Corp acquired a new position in shares of Conmed Corp. during the second quarter worth approximately $229,000. 98.80% of the stock is owned by hedge funds and other institutional investors.

A number of analysts recently issued reports on CNMD shares. Leerink Swann lowered shares of Conmed Corp. from an “outperform” rating to a “market perform” rating and dropped their price target for the stock from $56.00 to $47.00 in a research note on Thursday, July 28th. Zacks Investment Research lowered shares of Conmed Corp. from a “hold” rating to a “sell” rating in a research note on Friday, July 29th.

Conmed Corp. Company Profile

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Its products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.

5 Day Chart for NASDAQ:CNMD

Receive News & Stock Ratings for Conmed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conmed Corp. and related stocks with our FREE daily email newsletter.